Release Date: 04/05/21 08:26 Summary: Agreement with Ilara Health to sell ResAppDx in Kenya Price Sensitive: Yes Download Document 118.61KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%